Aurobindo Pharma Cash Flow Annual

Trade
BSE: 524804 | NSE: AUROPHARMA | ISIN: INE406A01037 | Sector: Major Drugs
1,236.35 +12.70 (1.04%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Net Income/ Starting Line 4,379.992,612.503,372.747,343.59
Depreciation/ Depletion 1,521.661,244.581,126.521,055.39
Non- Cash Items -25.42341.89217.61-2,718.03
Changesin Working Capital -3,441.71-1,805.81296.36-2,329.62
Cashfrom Operating Activities 2,434.522,393.165,013.233,351.33
Capital Expenditures -3,561.50-2,720.40-2,704.64-1,873.81
Other Investing Cash Flow Items Total -694.45-1,257.35-506.922,472.50
Cashfrom Investing Activities -4,255.95-3,977.75-3,211.56598.69
Financing Cash Flow Items -250.65-111.20-18.50-48.06
Total Cash Dividends Paid -263.64-439.53-263.70-234.31
Issuance( Retirement)of Debt Net 1,314.712,365.14-2,687.07-1,082.44
Cashfrom Financing Activities 800.421,814.41-2,969.27-1,364.81
Foreign Exchange Effects 14.17-0.060.20-2.12
Net Changein Cash -1,006.84229.76-1,167.402,583.09
Cash Interest Paid 250.65111.2018.5048.06
Cash Taxes Paid 1,766.64717.241,258.191,285.25
Issuance( Retirement)of Stock Net ---0.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts